MedPath

The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome

Phase 4
Recruiting
Conditions
Carpal Tunnel Syndrome
Hand Injuries and Disorders
Nerve Compression
Splints
Carpal Tunnel
Carpal Tunnel Release
Registration Number
NCT04460521
Lead Sponsor
Emily Krauss
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> 1. The patient has a confirmed diagnosis of mild to moderate idiopathic unilateral or<br> bilateral CTS as determined by both clinical exam findings and electrodiagnostic<br> nerve conduction studies (median nerve distal motor latency = 4.3 milliseconds<br> and/or median nerve sensory distal latency = 3.5 milliseconds at the wrist)<br> performed within the preceding year prior to enrollment<br><br> 2. Symptoms of CTS must have been present for = 6 weeks<br><br> 3. The patient must be = 18 years of age.<br><br>Exclusion Criteria:<br><br> 1. Any previous carpal tunnel release procedure on the ipsilateral limb<br><br> 2. Any previous corticosteroid injection in the last 6 months on the ipsilateral limb<br><br> 3. Severe CTS/signs of median nerve denervation with axonal loss determined by constant<br> wrist or hand pain, constant parasthesias in the median nerve distribution, or<br> thenar muscle atrophy in the ipsilateral limb<br><br> 4. Any known or suspected allergy to NAC<br><br> 5. Any current medications which preclude use of NAC including antibiotics or<br> nitroglycerin<br><br> 6. Breastfeeding patients or patients with nephrolithiasis<br><br> 7. Any history of proximal ipsilateral neck or proximal limb injury<br><br> 8. Secondary CTS related to pregnancy<br><br> 9. Unable for financial reasons to obtain a night splint (i.e. lack of insurance<br> coverage or lack of financial means).

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from baseline Boston Carpal Tunnel Questionnaire (BCTQ) at 8 weeks
Secondary Outcome Measures
NameTimeMethod
Number of participants who elect to have surgical carpal tunnel decompression after 8 weeks;Number of participants who elect to have surgical carpal tunnel decompression after 6 months;Change from baseline Boston Carpal Tunnel Questionnaire (BCTQ) at 6 months
© Copyright 2025. All Rights Reserved by MedPath